Breast cancer is the most common malignancy associated with pregnancy and is a rare but well-recognized complication.1 A California registry study showed an incidence of 1.3 breast cancers diagnosed per 10,000 live births.2 It is hypothesized that as more women continue to delay childbearing, the incidence of breast cancer in pregnancy will increase.3 Because of the lack of clinical experience with breast cancer in the setting of pregnancy, given its relative infrequency, many patients and physicians perceive the diagnosis to be one that puts the life of the mother at odds with that of the fetus, but available data suggest that termination of the pregnancy does not improve the outcome for pregnant women with breast cancer.4 Often diagnosis is delayed because neither patient nor physician suspects malignancy. This report presents a recent case of a young primigravid woman with a newly appreciated breast mass seen at Northwestern University Feinberg School of Medicine as a means of discussing diagnostic considerations, therapeutic options, and supportive care available to the practitioner when managing a pregnant patient with breast cancer.
Anderson JM, Stimson WH, Gettinby G. Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA). Eur J Cancer 1979;15:709–714.
Smith LH, Dalrymple JL, Leiserowitz GS. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol 2001;184:1504–1512; discussion 1512–1513.
King RM, Welch JS, Martin JK Jr, Coulam CB. Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet 1985;160:228–232.
Yang WT, Dryden MJ, Gwyn K. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology 2006;239:52–60.
Hahn KM, Johnson PH, Gordon N. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219–1226.
Gentilini O, Cremonesi M, Trifiro G. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348–1351.
Pandit-Taskar N, Dauer LT, Montgomery L. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med 2006;47:1202–1208.
Khera SY, Kiluk JV, Hasson DM. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008;14:250–254.
Mondi MM, Cuenca RE, Ollila DW. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 2007;14:218–221.
Berry DL, Theriault RL, Holmes FA. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855–861.
Carlson RW, Allred DC, Anderson BO. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 2, 2011. Available at: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed January 9, 2012.
Mir O, Berveiller P, Ropert S. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008;19:607–613.
Bader AA, Schlembach D, Tamussino KF. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79–81.
Donnelly EH, Smith JM, Farfan EB, Ozcan I. Prenatal radiation exposure: background material for counseling pregnant patients following exposure to radiation. Disaster Med Public Health Prep 2011;5:62–68.
Annane K, Bellocq JP, Brettes JP, Mathelin C. Infiltrative breast cancer during pregnancy and conservative surgery. Fetal Diagn Ther 2005;20:442–444.
Kuerer HM, Gwyn K, Ames FC, Theriault RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 2002;131:108–110.